| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |